Welcome to our dedicated page for Danaher Corporation SEC filings (Ticker: DHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Danaher Corporation (NYSE: DHR) SEC filings page provides access to the company’s official regulatory documents filed with the U.S. Securities and Exchange Commission. These filings include current reports on Form 8‑K, quarterly reports on Form 10‑Q and other disclosures that detail Danaher’s financial performance, governance changes and capital markets activities as a global life sciences and diagnostics innovator.
Danaher uses Form 8‑K filings to report material events such as quarterly and annual financial results, estimated financial performance ahead of investor conferences, amendments to its by‑laws, share repurchase authorizations and changes in senior leadership or board composition. For example, the company has filed 8‑Ks to furnish earnings press releases and presentation slides, to describe updates to its by‑laws regarding shareholder proposal and nomination procedures, and to outline a share repurchase program authorizing the repurchase of up to 35 million shares of common stock.
The filings also list Danaher’s securities registered under Section 12(b) of the Exchange Act, including its common stock and multiple series of senior notes with various maturities, all traded on the New York Stock Exchange. This information helps investors understand the company’s capital structure and the instruments available in public markets.
Through its periodic reports, Danaher provides detailed financial statements, management’s discussion and analysis, and explanations of non‑GAAP measures such as core sales growth and adjusted diluted net earnings per common share. The company explains how it calculates these measures, why management uses them and how they reconcile to the most directly comparable GAAP figures, including adjustments for amortization of acquisition‑related intangible assets, fair value gains and losses on investments, impairments and tax effects.
On Stock Titan, users can review these SEC filings alongside AI‑powered summaries that highlight key points, such as revenue trends, margin drivers, capital allocation decisions, governance changes and risk disclosures. The platform’s tools can help readers quickly understand the implications of Danaher’s 10‑Q and 10‑K reports, as well as 8‑K items related to dividends, share repurchases, executive transitions and by‑law amendments, while still allowing detailed review of the original documents.
Danaher Corporation executive Jose-Carlos Gutierrez-Ramos reported the vesting of 1,695 shares of common stock. The shares were acquired on February 4, 2026 at a price of $0.00 per share following achievement of performance criteria under a 2023 performance stock unit award.
After this transaction, he beneficially owned 12,999 shares of Danaher common stock in direct form. The vested award remains subject to a holding period that continues through December 31, 2027, meaning the shares are restricted from sale until that date.
Danaher Corporation reported an insider equity award for SVP of Human Resources, Georgeann Couchara. On February 4, 2026, she acquired 1,413 shares of common stock at $0 per share, following the achievement of performance criteria tied to earlier granted performance stock units.
These units were originally awarded on February 24, 2023 under the Danaher Corporation 2007 Omnibus Incentive Plan. The resulting shares are subject to a holding period that continues through December 31, 2027. After this transaction, Couchara beneficially owns 4,038 shares of Danaher common stock directly.
Danaher Corporation Executive Vice President Julie A. Sawyer Montgomery reported an equity award tied to prior performance. On February 4, 2026, she acquired 848 shares of Danaher common stock at $0 per share, following the Compensation Committee’s determination that performance criteria for earlier-granted performance stock units were achieved.
After this transaction, she beneficially owns 17,501 shares of Danaher common stock in direct ownership. The award remains subject to a holding period that runs through December 31, 2027, meaning the shares are restricted until that date under the company’s incentive plan terms.
Danaher Corporation President & CEO Rainer Blair reported the acquisition of 8,474 shares of common stock on February 4, 2026 at a price of $0. These shares resulted from performance stock units granted in 2023 after the compensation committee determined the performance criteria were achieved.
Following this transaction, Blair directly owns 20,422 common shares and indirectly owns 58,255 shares through a trust. The award remains subject to a holding period that continues through December 31, 2027, meaning the shares must be held until that date.
Danaher Corporation reported an insider share award for its EVP & Chief Financial Officer, Matthew McGrew. On February 4, 2026, he acquired 2,684 shares of common stock at $0, following the Compensation Committee’s determination that performance criteria for previously granted performance stock units had been achieved.
The performance stock units were originally awarded on February 24, 2023 under the Danaher Corporation 2007 Omnibus Incentive Plan and remain subject to a holding period through December 31, 2027. After this transaction, McGrew directly owned 20,890 common shares and indirectly held 10,232.549 shares through a 401(k) plan.
Danaher Corporation Executive Vice President Gregory M. Milosevich reported an award of common stock under a long-term incentive plan. On February 4, 2026, he acquired 679 shares of Danaher common stock at $0 per share, tied to previously granted performance stock units.
The Compensation Committee determined that the performance criteria for a February 24, 2023 award had been achieved, triggering this share delivery. The award remains subject to a holding period through December 31, 2027. Following the transaction, Milosevich beneficially owns 5,099 shares of Danaher common stock directly.
Danaher Corporation SVP and Chief Science Officer Jose-Carlos Gutierrez-Ramos reported routine equity-related transactions. On February 2, 2026, 852 shares of Danaher common stock were withheld at $223.42 per share to cover taxes tied to performance-based restricted stock units, leaving 11,304 shares of common stock held directly.
On the same date, the company made its annual contribution to his Danaher deferred compensation account, crediting 275 notional shares in the Danaher Stock Fund at a reference price of $218.89 per share. Following this, he held 1,447.296 notional shares directly in the deferred compensation programs, which convert into common stock on a one-for-one basis under plan terms.
Danaher Corporation executive Brian W. Ellis, Senior Vice President and General Counsel, reported routine equity-related transactions. On February 2, 2026, 1,254 shares of Danaher common stock were withheld at $223.42 per share to cover taxes tied to performance-based restricted stock units, leaving him with 13,299 directly held common shares.
On the same date, the company made its annual contribution to his Danaher stock fund account under deferred compensation programs, credited as 251 unfunded, notional shares at $218.89 per share. These notional shares track Danaher common stock one-for-one, with 6,944.632 notional shares held after the transaction.
Danaher Corporation Executive Vice President Julie A. Sawyer Montgomery reported an annual company contribution under Danaher’s deferred compensation program. On February 2, 2026, her account received 510 notional units of the Danaher Stock Fund at a reference price of $218.89 per share.
These are unfunded, notional shares of Danaher common stock that convert on a one-for-one basis under the plan’s terms. Following this transaction, she holds 2,177.291 derivative units tied to Danaher common stock in the deferred compensation program, reflecting compensation rather than an open-market purchase or sale.
Danaher Corporation executive Christopher Bouda received additional notional stock units under the company’s deferred compensation program. On 02/02/2026, the VP and Chief Accounting Officer was credited with 189 notional shares tied to Danaher common stock at a reference price of $218.89 per share.
These units represent the company’s annual contribution to Bouda’s account in the Danaher stock fund and are unfunded, notional shares that convert on a one-for-one basis with Danaher common stock. Following this transaction, Bouda holds a total of 2,738.957 notional shares in the deferred compensation stock fund.